Abstract
Allogeneic SCT is curative for bone marrow failure in Fanconi anemia (FA) patients but the optimal conditioning regimen is undetermined. We report here our experience with 56 FA patients who underwent allogeneic matched related SCT. The conditioning regimen varied according to time of SCT and disease status at SCT; 22 patients (group A) received Cy 20 mg/kg, thoraco-abdominal radiation and antithymocyte globulins (ATG); and 34 patients (group B) received Cy 60 mg/kg and ATG. Median time to engraftment was similar (14 days) in both groups. Hemorrhagic cystitis was significantly more common in group B. Overall survival and event-free survival of all patients were 85 and 78.3% respectively. For groups A and B respectively, overall survival was 72.5 and 96.9% (P=0.013); and event-free survival was 72.5 and 82.3% (P=0.3). The use of the nonradiation Cy/ATG regimen in matched related SCT for FA patients offers better overall and event-free survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Sieff CA, Nisbet-Brown E, Nathan D . Congenital bone marrow syndromes failures. Br J Haematol 2000; 111: 30–42.
Alter BP . Hematologic abnormalities in Fanconi anemia. Blood 1995; 85: 1148–1149.
Auerbach AD, Weiner MA, Warburton D, Yeboa K, Lu L, Broxmeyer HE . Acute myeloid leukemia as the first hematologic manifestation of Fanconi anemia. Am J Hematol 1982; 12: 289–300.
Rosenberg PS, Greene MH, Alter BP . Cancer incidence in persons with Fanconi anemia. Blood 2003; 101: 822–826.
Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD . Hematologic abnormalities in Fanconi anemia: an international Fanconi anemia registry study. Blood 1994; 84: 1650–1655.
Flowers ME, Doney KC, Storb R, Deeg HJ, Sanders JE, Sullivan KM et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplant 1992; 9: 167–173.
Flowers ME, Zanis J, Pasquini R, Deeg HJ, Ribeiro R, Longton G et al. Marrow transplantation for Fanconi anemia: conditioning with reduced doses of cyclophosphamide without radiation. Br J Haematol 1996; 92: 699–706.
Gluckman E . Allogeneic bone marrow transplantation in Fanconi anemia. Bone Marrow Transplant 1996; 18: S33–S35.
Medeiros CR, Zanis-Neto J, Pasquini R . Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant 1999; 24: 849–852.
Gluckman E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM et al. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86: 2856–2862.
Zanis-Neto J, Flowers MED, Medeiros CR, Bitencourt MA, Bonfim CM, Setubal DC et al. Low dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia. Br J Haematol 2005; 130: 99–106.
Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Moussa E, Karaoui M et al. Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation. Bone Marrow Tranpslant 2004; 33: 15–17.
Dufour C, Rondelli R, Locatelli F, Miano M, Di Girolamo G, Bacigalupo A et al. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO. Br J Haematol 2001; 112: 796–805.
Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Al-Seraihi A, Tbakhi A et al. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy. Bone Marrow Tranpslant 2005; 35: 463–466.
Socié G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H et al. Transplantation for Fanconi's anaemia: long-term follow up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998; 103: 249–255.
Sullivan KM . Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, 1997, pp 339.
Berger R, Bernheim A, Gluckman E, Gisselbrecht C . In vitro effect of cyclophophamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol 1980; 45: 565–568.
Gluckman E, Devergie A, Dutreix J . Radiosensitivity in Fanconi anemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54: 431–440.
Kohli-Kumar M, Morris C, DeLaat C, Sambrano J, Masterson M, Mueller R et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994; 84: 2050–2054.
Ayas M, Solh H, Mustafa MM, Al-Mahr M, Al-Fawaz I, Al-Jefri A et al. Bone marrow transplantation from matched siblings in patients with Fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant 2001; 27: 139–143.
Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A et al. Malignancies after marrow transplantation for aplastic and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87: 386–392.
Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF et al. A 20-year perspective on the international Fanconi anemia registry (IFAR). Blood 2003; 101: 1249–1256.
Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol 2003; 129: 106–112.
Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML . Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 2006; 46: 630–636.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ayas, M., Al-Jefri, A., Al-Seraihi, A. et al. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience. Bone Marrow Transplant 42 (Suppl 1), S45–S48 (2008). https://doi.org/10.1038/bmt.2008.114
Published:
Issue date:
DOI: https://doi.org/10.1038/bmt.2008.114
Keywords
This article is cited by
-
First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group
Bone Marrow Transplantation (2017)
-
Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only
Annals of Hematology (2015)
-
Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine
Bone Marrow Transplantation (2010)